The EU Court ruled against the Commission for failing to justify its refusal to release texts between von der Leyen and ...

Biotech company Alnylam Pharmaceuticals conceded defeat for now in a lawsuit against Pfizer and BioNTech over technology in ...

We recently published a list of 13 Stocks on Jim Cramer’s Radar Recently. In this article, we are going to take a look at ...

The European Court of Justice Wednesday ruled there was no plausible reason to block the New York Times from getting European ...

In 2024 alone, Singapore secured S$13.5 billion in fixed asset investment commitments, with the biomedical sector ...

A top European court says the European Commission was wrong to refuse the New York Times access to text messages sent between ...

A top court Wednesday ruled the European Commission failed the transparency test by declining to release text messages sent ...

Revisions to classification criteria ‘will ensure homogeneous trial populations’ with data-driven scoring, a standardized MRI ...

Europe's second-top court on Wednesday dismissed the European Commission's rejection of a New York Times' request to access text messages between its President Ursula von der Leyen and Pfizer CEO ...

A top court is to rule Wednesday on whether the EU failed the transparency test by declining to release text messages sent by ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...